Literature DB >> 31228567

Follow-Up of Patients With Ulcerative Colitis and Histological Normalization.

Amanda Israel1, Britt Christensen2, Katia El Jurdi1, Victoria Rai1, Jacob E Ollech1, Russell D Cohen1, Atsushi Sakuraba1, Sushila R Dalal1, David T Rubin3.   

Abstract

The natural history of ulcerative colitis (UC) follows a relapsing and remitting course of inflammation and is accompanied by associated mucosal injury and historically, microscopic features of chronicity that were the sine qua non for the diagnosis.1 As goals for the management of UC have evolved to include objectively measured endoscopic improvement of the mucosa, there also has been a move to include histological endpoints in assessment of disease activity.2,3 However, there remain a number of unanswered questions about histology in UC and this is not yet a specific treatment goal.4.
Copyright © 2020 AGA Institute. Published by Elsevier Inc. All rights reserved.

Entities:  

Year:  2019        PMID: 31228567      PMCID: PMC6923607          DOI: 10.1016/j.cgh.2019.06.025

Source DB:  PubMed          Journal:  Clin Gastroenterol Hepatol        ISSN: 1542-3565            Impact factor:   11.382


  7 in total

1.  Clinical, biological, and histologic parameters as predictors of relapse in ulcerative colitis.

Authors:  A Bitton; M A Peppercorn; D A Antonioli; J L Niles; S Shah; A Bousvaros; B Ransil; G Wild; A Cohen; M D Edwardes; A C Stevens
Journal:  Gastroenterology       Date:  2001-01       Impact factor: 22.682

2.  Histologic Remission in Ulcerative Colitis: Are We There Yet?

Authors:  Millie D Long; David T Rubin
Journal:  Am J Gastroenterol       Date:  2019-05       Impact factor: 10.864

3.  ACG Clinical Guideline: Ulcerative Colitis in Adults.

Authors:  David T Rubin; Ashwin N Ananthakrishnan; Corey A Siegel; Bryan G Sauer; Millie D Long
Journal:  Am J Gastroenterol       Date:  2019-03       Impact factor: 10.864

4.  Histologic Normalization Occurs in Ulcerative Colitis and Is Associated With Improved Clinical Outcomes.

Authors:  Britt Christensen; Stephen B Hanauer; Jonathan Erlich; Olufemi Kassim; Peter R Gibson; Jerrold R Turner; John Hart; David T Rubin
Journal:  Clin Gastroenterol Hepatol       Date:  2017-02-24       Impact factor: 11.382

5.  Inflammation is an independent risk factor for colonic neoplasia in patients with ulcerative colitis: a case-control study.

Authors:  David T Rubin; Dezheng Huo; Jami A Kinnucan; Mina S Sedrak; Nicole E McCullom; Alana P Bunnag; Elin P Raun-Royer; Russell D Cohen; Stephen B Hanauer; John Hart; Jerrold R Turner
Journal:  Clin Gastroenterol Hepatol       Date:  2013-07-17       Impact factor: 11.382

6.  Microscopic activity in ulcerative colitis: what does it mean?

Authors:  S A Riley; V Mani; M J Goodman; S Dutt; M E Herd
Journal:  Gut       Date:  1991-02       Impact factor: 23.059

Review 7.  Histologic remission: the ultimate therapeutic goal in ulcerative colitis?

Authors:  Laurent Peyrin-Biroulet; Aude Bressenot; Wendy Kampman
Journal:  Clin Gastroenterol Hepatol       Date:  2013-08-01       Impact factor: 11.382

  7 in total
  2 in total

1.  Predictors and outcomes of histological remission in ulcerative colitis treated to endoscopic healing.

Authors:  Sushrut Jangi; Hyuk Yoon; Parambir S Dulai; Mark Valasek; Brigid S Boland; Vipul Jairath; Brian G Feagan; William J Sandborn; Siddharth Singh
Journal:  Aliment Pharmacol Ther       Date:  2020-08-09       Impact factor: 8.171

2.  Segmental Histological Normalisation Occurs in Ulcerative Colitis but Does Not Improve Clinical Outcomes.

Authors:  Britt Christensen; Stephen B Hanauer; Peter R Gibson; Jerrold R Turner; John Hart; David T Rubin
Journal:  J Crohns Colitis       Date:  2020-10-05       Impact factor: 10.020

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.